US Broker Ratings

Exact Sciences Corporation (EXAS) Stock Analysis: A 2.55% Upside in a Booming Healthcare Sector

Exact Sciences Corporation (NASDAQ: EXAS) is commanding attention in the healthcare sector, particularly within the diagnostics and research industry. With a market capitalization of $19.6 billion,..

argenx SE (ARGX) Stock Analysis: Exploring a 27.65% Potential Upside in the Biotech Sector

argenx SE (NASDAQ: ARGX) stands as a formidable player in the biotechnology industry, particularly within the realm of autoimmune disease therapies. With a market capitalization of..

Vaxcyte, Inc. (PCVX)

⚠️ No article content returned.

..

BridgeBio Pharma, Inc. (BBIO) Stock Analysis: Unveiling a 37.11% Potential Upside in the Biotech Sector

BridgeBio Pharma, Inc. (NASDAQ: BBIO), a leading player in the biotechnology sector, is drawing significant interest from investors, evidenced by a substantial market capitalization of $13.04..

ADMA Biologics Inc (ADMA) Stock Analysis: Attractive 56.22% Upside Potential for Investors

ADMA Biologics Inc (NASDAQ: ADMA) is capturing investor attention with a remarkable potential upside of 56.22%, according to analyst ratings. This biopharmaceutical company, based in Ramsey,..

Integer Holdings Corporation (ITGR) Stock Analysis: Navigating the Medical Device Landscape with Strategic Growth

Integer Holdings Corporation (NYSE: ITGR) stands as a formidable player in the healthcare sector, specifically within the medical devices industry. With a market capitalization of $3.03..

Regeneron Pharmaceuticals, Inc. (REGN) Stock Analysis: Assessing a Potential 9.97% Upside in the Biotechnology Sector

Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN), a stalwart in the biotechnology industry, has positioned itself as a critical player in the healthcare sector with its diverse portfolio..

Telix Pharmaceuticals Limited (TLX): Investor Outlook Highlights 206% Upside Potential

Telix Pharmaceuticals Limited (TLX), an emerging titan in the healthcare sector, is captivating investor attention with its promising pipeline and a striking potential upside of 206.21%...

Henry Schein, Inc. (HSIC) Stock Analysis: Evaluating Its Unique Position in the Medical Distribution Sector

Henry Schein, Inc. (NASDAQ: HSIC) stands as a formidable player in the healthcare sector, specifically within the medical distribution industry. With a robust market capitalization of..

Bio-Rad Laboratories, Inc. (BIO) Stock Analysis: Unpacking a 15% Potential Upside

Bio-Rad Laboratories, Inc. (NYSE: BIO), a key player in the healthcare sector, is drawing significant attention from investors with its promising 15.42% potential upside. Specializing in..

TransMedics Group, Inc. (TMDX) Stock Analysis: A Healthcare Innovator with 6.77% Potential Upside

TransMedics Group, Inc. (TMDX) has been capturing the attention of investors with its pioneering approach in the medical devices sector, particularly in the field of organ..

Nuvalent, Inc. (NUVL): Analyst Ratings Signal 36.79% Upside in Biotech Innovator

Nuvalent, Inc. (NASDAQ: NUVL), a clinical-stage biopharmaceutical company, stands out in the biotechnology sector with a market capitalization of $8.04 billion. Headquartered in Cambridge, Massachusetts, Nuvalent..

Lantheus Holdings, Inc. (LNTH) Stock Analysis: Unlocking a 28.62% Potential Upside for Investors

Lantheus Holdings, Inc. (NASDAQ: LNTH) stands as a formidable player in the healthcare sector, with a particular focus on the specialty and generic drug manufacturing industry...

Waystar Holding Corp. (WAY) Stock Analysis: A 90.80% Potential Upside Amid Robust Analyst Support

Waystar Holding Corp. (NASDAQ: WAY), a key player in the healthcare information services sector, is capturing the attention of investors with its promising growth potential and..

AptarGroup, Inc. (ATR) Stock Analysis: A 19% Upside Potential in the Healthcare Sector

AptarGroup, Inc. (NYSE: ATR), a leading player in the healthcare sector specializing in medical instruments and supplies, stands out as a compelling investment opportunity with a..

Smith & Nephew SNATS, Inc. (SNN) Stock Analysis: Evaluating a Potential 4.99% Upside in the Healthcare Sector

Smith & Nephew SNATS, Inc. (NYSE: SNN), a stalwart in the healthcare sector, particularly in the medical devices industry, is attracting attention from investors with an..

United Therapeutics Corporation (UTHR) Stock Analysis: Exploring a 9.46% Potential Upside and Robust Growth Prospects

United Therapeutics Corporation (NASDAQ: UTHR), a leading player in the healthcare sector, specializes in addressing critical medical needs through innovative treatments for chronic and life-threatening diseases...

Legend Biotech Corporation (LEGN) Stock Analysis: A 275% Upside Potential Amid Strong Analyst Support

Legend Biotech Corporation (NASDAQ: LEGN) is a promising player in the biotechnology sector, focusing on innovative cell therapies for treating cancer. With a market capitalization of..

GSK plc (GSK) Stock Analysis: Navigating a 60.23 USD Peak Amidst Potential Downside Risk

GSK plc (NYSE: GSK), a formidable player in the healthcare sector, has been making waves with its robust portfolio of vaccines and specialty medicines. With a..

Bruker Corporation (BRKR) Stock Analysis: Unveiling a 29.81% Potential Upside in the Medical Devices Sector

For investors seeking opportunities in the healthcare sector, Bruker Corporation (NASDAQ: BRKR) presents an intriguing prospect. With a market capitalization of $6.37 billion, this Massachusetts-based company..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds